```

[Federal Register Volume 77, Number 200 (Tuesday, October 16, 2012)]
[Notices]
[Pages 63297-63298]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25373]

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary

[Docket ID DoD-2012-HA-0126]

Proposed Collection; Comment Request

AGENCY: Office of the Assistant Secretary of Defense for Health 
Affairs, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

    In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction 
Act of 1995, the Office of the Assistant Secretary of Defense for 
Health Affairs announces a proposed public information collection and 
seeks public comment on the provisions thereof. Comments are invited 
on: (a) whether the proposed collection of information is necessary for 
the proper performance of the functions of the agency, including 
whether the information shall have practical utility; (b) the accuracy 
of the agency's estimate of the burden of the proposed information 
collection; (c) ways to enhance the quality, utility, and clarity of 
the information to be collected; and (d) ways to minimize the burden of 
the information collection on respondents, including through the use of 
automated collection techniques or other forms of information 
technology.

DATES: Consideration will be given to all comments received December 
17, 2012.

ADDRESSES: You may submit comments, identified by docket number and 
title, by any of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Federal Docket Management System Office, 4800 Mark 
Center Drive, East Tower, Suite 02G09, Alexandria, VA 22350-3100.
    Instructions: All submissions received must include the agency 
name, docket number and title for this Federal Register document. The 
general policy for comments and other submissions from members of the 
public is to make these submissions available for public viewing on the 
Internet at http://www.regulations.gov as they are received without 
change, including any personal identifiers or contact information.

FOR FURTHER INFORMATION CONTACT: To request more information on this 
proposed information collection or to obtain a copy of the proposal and 
associated collection instruments, please write to: CAPT Nita Sood, 
TRICARE Management Activity, Pharmaceutical Operations Directorate, 
7700 Arlington Boulevard, Falls Church, VA 22042-5101.
    Title; Associated Form; and OMB Number: Federal Agency Retail 
Pharmacy Program; OMB Number 0720-0032.
    Needs and Uses: Specifically, under the collection of information, 
respondents (drug manufacturers) will base refund calculation reporting 
requirements on both the Federal Ceiling Price and the Federal Supply 
Schedule Price, whichever is lower. Previously, drug manufacturers' 
reporting requirements addressed only the Federal Ceiling Price. DoD 
will use the reporting and audit capabilities of the Pharmacy Data 
Transaction Service (PDTS) to validate refunds owed to the Government. 
The government received approximately $1.5 billion from pharmaceutical 
companies as a result of this program/refund calculation reporting 
requirement.
    Affected Public: Business or other for profit.
    Annual Burden Hours: 16,000.
    Number of Respondents: 250.
    Responses per Respondent: 8.

[[Page 63298]]

    Average Burden Per Response: 8 hours.
    Frequency: On occasion.

SUPPLEMENTARY INFORMATION:

Summary of Information Collection

    Title 10, United States Code (U.S.C.) 1074g(f) makes drugs provided 
to eligible covered beneficiaries through the TRICARE Retail Pharmacy 
Program subject to the pricing standards of the Veterans Health Care 
Act. Under the authority of 10 U.S.C. 1074g(h), Title 32, Code of 
Federal Regulation (CFR) 199.21(q)(3) requires information collection 
to implement 10 U.S.C. 1074g(f). Specifically, under the collection of 
information, respondents (drug manufacturers) will base refund 
calculation reporting requirements on both the Federal Ceiling Price 
and the Federal Supply Schedule Price, whichever is lower. Previously, 
drug manufacturers' reporting requirements addressed only the Federal 
Ceiling Price. The DoD will use the reporting and audit capabilities of 
the Pharmacy Data Transaction Service (PDTS) to validate refunds owed 
to the Government.

    Dated: October 11, 2012.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2012-25373 Filed 10-15-12; 8:45 am]
BILLING CODE 5001-06-P
```